{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:26:08Z","timestamp":1791278768804,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.vaccine.2007.08.061","type":"journal-article","created":{"date-parts":[[2007,9,19]],"date-time":"2007-09-19T15:35:18Z","timestamp":1190216118000},"page":"8480-8485","source":"Crossref","is-referenced-by-count":72,"title":["Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease"],"prefix":"10.1016","volume":"25","author":[{"given":"Jon L.","family":"Belsher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margo","family":"Brinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"DellaValla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ridenour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lanciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Perelygin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Paddock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Querec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuofu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bali","family":"Pulendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel B.","family":"Eidex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2007.08.061_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.qco.0000178823.28585.ad","article-title":"New developments in flavivirus vaccines with special attention to yellow fever","volume":"18","author":"Pugachev","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2007.08.061_bib2","series-title":"Yellow fever vaccine","author":"Monath","year":"2004"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.061_bib3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14760584.4.4.553","article-title":"Yellow fever vaccine","volume":"4","author":"Monath","year":"2005","journal-title":"Expert Rev Vaccines"},{"issue":"9276","key":"10.1016\/j.vaccine.2007.08.061_bib4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.vaccine.2007.08.061_bib5","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"issue":"9438","key":"10.1016\/j.vaccine.2007.08.061_bib6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(04)17017-7","article-title":"History of thymoma and yellow fever vaccination","volume":"364","author":"Barwick","year":"2004","journal-title":"Lancet"},{"issue":"9276","key":"10.1016\/j.vaccine.2007.08.061_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2007.08.061_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jcv.2006.02.005","article-title":"Yellow fever vaccine-associated viscerotropic disease and death in Spain","volume":"36","author":"Doblas","year":"2006","journal-title":"J Clin Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.08.061_bib9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.SMJ.0000157537.11806.DC","article-title":"Rare case of fatal yellow fever vaccine-associated viscerotropic disease","volume":"98","author":"Gerasimon","year":"2005","journal-title":"South Med J"},{"issue":"14","key":"10.1016\/j.vaccine.2007.08.061_bib10","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1073\/pnas.142287799","article-title":"Positional cloning of the murine flavivirus resistance gene","volume":"99","author":"Perelygin","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.061_bib11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CDLI.2.3.302-306.1995","article-title":"Lymphocytic 2\u2032,5\u2032-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine","volume":"2","author":"Bonnevie-Nielsen","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.061_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20051970","article-title":"CCR5 deficiency increases risk of symptomatic West Nile virus infection","volume":"203","author":"Glass","year":"2006","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.vaccine.2007.08.061_bib13","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1086\/497340","article-title":"Single nucleotide polymorphisms in genes for 2\u2032\u20135\u2032-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection","volume":"192","author":"Yakub","year":"2005","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2007.08.061_bib14","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.humpath.2006.05.011","article-title":"Immunohistochemical evidence of Clostridium sp, Staphylococcus aureus, and group A Streptococcus in severe soft tissue infections related to injection drug use","volume":"37","author":"Guarner","year":"2006","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.08.061_bib15","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.4049\/jimmunol.172.5.3189","article-title":"HIV-infected lymphocytes regulate fibronectin synthesis by TGF beta 1 secretion","volume":"172","author":"Pal","year":"2004","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.08.061_bib16","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1086\/423209","article-title":"Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1","volume":"190","author":"Liu","year":"2004","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2007.08.061_bib17","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1086\/499820","article-title":"Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility","volume":"193","author":"Liu","year":"2006","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.061_bib18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/infdis\/169.3.512","article-title":"Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis","volume":"169","author":"Jennings","year":"1994","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.061_bib19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1086\/429391","article-title":"Variation in antiviral 2\u2032,5\u2032-oligoadenylate synthetase (2\u20325\u2032AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene","volume":"76","author":"Bonnevie-Nielsen","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"7","key":"10.1016\/j.vaccine.2007.08.061_bib20","first-page":"BR235","article-title":"Three-dimensional models of human 2\u2032\u20135\u2032 oligoadenylate synthetases: a new computational method for reconstructing an enzyme assembly","volume":"11","author":"Torshin","year":"2005","journal-title":"Med Sci Monit"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.061_bib21","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.bbrc.2005.02.101","article-title":"Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population","volume":"329","author":"Hamano","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.vaccine.2007.08.061_bib22","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1086\/503841","article-title":"Fatal hemorrhagic fever caused by West Nile virus in the United States","volume":"42","author":"Paddock","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2007.08.061_bib23","first-page":"653","article-title":"Clinical features of yellow fever cases at Vom Christian Hospital during the 1969 epidemic on the Jos Plateau, Nigeria","volume":"46","author":"Jones","year":"1972","journal-title":"Bull World Health Organ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,26]],"date-time":"2020-04-26T17:06:37Z","timestamp":1587920797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07009814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":23,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0264410X07009814"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.08.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}